-
Je něco špatně v tomto záznamu ?
Antimicrobial Activity of the Most Common Antibiotic-Releasing Systems Employed in Current Orthopedic Surgery: in vitro Study [Antimikrobiální účinnost nejběžnějších systémů uvolňujících antibiotika, které se používají v současné ortopedické chirurgii: in vitro studie]
R. Štícha, P. Fulín, O. Nyč, V. Gajdošová, D. Pokorný, M. Šlouf
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
PubMed
37395426
Knihovny.cz E-zdroje
- MeSH
- agar MeSH
- antibakteriální látky farmakologie terapeutické užití MeSH
- kostní cementy farmakologie terapeutické užití MeSH
- lidé MeSH
- ortopedické výkony * MeSH
- ortopedie * MeSH
- polymethylmethakrylát chemie MeSH
- reprodukovatelnost výsledků MeSH
- síran vápenatý MeSH
- vankomycin farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE OF THE STUDY Infections of joint replacements represent one of the most serious problems in contemporary orthopedics. The joint infections treatment is usually multimodal and involves various combinations of drug delivery and surgical procedures. The aim of this study was to evaluate and compare the bacteriostatic and bactericidal properties of the most common antibiotic carriers used in orthopedic surgery: bone cements mixed with antibiotic and porous calcium sulfate mixed with antibiotic. MATERIAL AND METHODS Three commercial bone cements (Palacos®, Palacos® R+G, Vancogenx®) and commercial porous sulfate (Stimulan®) were prepared with a known concentration of vancomycin (a glycopeptide antibiotic). Specifically, for the purpose of our study, the testing specimens were prepared to release 0, 1, 2, 4, 8, 16, 32, 64, 128, 256, and 512 mg of vancomycin into 1 liter of solution. The specimens with increasing amount of antibiotic were placed in a separate tubes containing 5 mL of Mueller-Hinton broth inoculated with a suspension (0.1 m, McFarland 1) of the reference strain CCM 4223 Staphylococcus aureus to evaluate their bacteriostatic properties (broth dilution method). After this initial incubation and evaluation of the broth dilution method, an inoculum from each tube was transferred onto blood agar plates. After another 24-hour incubation under the same conditions, we evaluated the bactericidal properties (agar plate method). As many as 132 of independent experiments were performed (4 specimens × 11 concentrations × 3 repetitions = 132). RESULTS The bacteriostatic properties of all investigated samples were excellent, perhaps with the exception of the first bone cement (Palacos®). The sample Palacos® started to exhibit bacteriostatic properties at concentrations ≥ 8 mg/mL, while all other samples (Palacos R+G®, Vancogenx®, and Stimulan®) were bacteriostatic in the whole concentration range starting from 1 mg/mL. The bacteriocidic properties did not show such clear trends, but correlated quite well with different properties of the investigated samples during mixing - the most homogeneous samples seemed to exhibit the best and the most reproducible results. DISCUSSION The reliable and reproducible comparison of ATB carriers is a difficult task. The situation is complicated by high numbers of local antibiotic carriers on the market, numerous antibiotics used, and differences in clinical trials at different laboratories. Simple in vitro testing of bacteriostatic and bacteriocidic properties represents a simple and efficient approach to the problem. CONCLUSIONS The study confirmed that the two most common commercial systems used in the orthopedic surgery (bone cements and porous calcium sulfate) prevent bacterial growth (bacteriostatic effect), but they may not be 100% efficient in complete elimination of bacteria (bacteriocidic effect). The scattered results in the case of bacteriocidic tests seemed to be connected with the homogeneity of ATB dispersion in the systems and with the lower reproducibility of the employed agar plate method. Key words: local release of antibiotics; bone cements; calcium sulfate; antimicrobial susceptibility.
Antimikrobiální účinnost nejběžnějších systémů uvolňujících antibiotika, které se používají v současné ortopedické chirurgii: in vitro studie
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23008965
- 003
- CZ-PrNML
- 005
- 20230802075155.0
- 007
- ta
- 008
- 230707s2023 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $2 doi $a 10.55095/achot2023/027
- 035 __
- $a (PubMed)37395426
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Štícha, Roman $u 1. Orthopedic Clinic First Faculty of Medicine Charles University and University Hospital in Motol, Prague $7 xx0244753
- 245 10
- $a Antimicrobial Activity of the Most Common Antibiotic-Releasing Systems Employed in Current Orthopedic Surgery: in vitro Study / $c R. Štícha, P. Fulín, O. Nyč, V. Gajdošová, D. Pokorný, M. Šlouf
- 246 31
- $a Antimikrobiální účinnost nejběžnějších systémů uvolňujících antibiotika, které se používají v současné ortopedické chirurgii: in vitro studie
- 520 9_
- $a PURPOSE OF THE STUDY Infections of joint replacements represent one of the most serious problems in contemporary orthopedics. The joint infections treatment is usually multimodal and involves various combinations of drug delivery and surgical procedures. The aim of this study was to evaluate and compare the bacteriostatic and bactericidal properties of the most common antibiotic carriers used in orthopedic surgery: bone cements mixed with antibiotic and porous calcium sulfate mixed with antibiotic. MATERIAL AND METHODS Three commercial bone cements (Palacos®, Palacos® R+G, Vancogenx®) and commercial porous sulfate (Stimulan®) were prepared with a known concentration of vancomycin (a glycopeptide antibiotic). Specifically, for the purpose of our study, the testing specimens were prepared to release 0, 1, 2, 4, 8, 16, 32, 64, 128, 256, and 512 mg of vancomycin into 1 liter of solution. The specimens with increasing amount of antibiotic were placed in a separate tubes containing 5 mL of Mueller-Hinton broth inoculated with a suspension (0.1 m, McFarland 1) of the reference strain CCM 4223 Staphylococcus aureus to evaluate their bacteriostatic properties (broth dilution method). After this initial incubation and evaluation of the broth dilution method, an inoculum from each tube was transferred onto blood agar plates. After another 24-hour incubation under the same conditions, we evaluated the bactericidal properties (agar plate method). As many as 132 of independent experiments were performed (4 specimens × 11 concentrations × 3 repetitions = 132). RESULTS The bacteriostatic properties of all investigated samples were excellent, perhaps with the exception of the first bone cement (Palacos®). The sample Palacos® started to exhibit bacteriostatic properties at concentrations ≥ 8 mg/mL, while all other samples (Palacos R+G®, Vancogenx®, and Stimulan®) were bacteriostatic in the whole concentration range starting from 1 mg/mL. The bacteriocidic properties did not show such clear trends, but correlated quite well with different properties of the investigated samples during mixing - the most homogeneous samples seemed to exhibit the best and the most reproducible results. DISCUSSION The reliable and reproducible comparison of ATB carriers is a difficult task. The situation is complicated by high numbers of local antibiotic carriers on the market, numerous antibiotics used, and differences in clinical trials at different laboratories. Simple in vitro testing of bacteriostatic and bacteriocidic properties represents a simple and efficient approach to the problem. CONCLUSIONS The study confirmed that the two most common commercial systems used in the orthopedic surgery (bone cements and porous calcium sulfate) prevent bacterial growth (bacteriostatic effect), but they may not be 100% efficient in complete elimination of bacteria (bacteriocidic effect). The scattered results in the case of bacteriocidic tests seemed to be connected with the homogeneity of ATB dispersion in the systems and with the lower reproducibility of the employed agar plate method. Key words: local release of antibiotics; bone cements; calcium sulfate; antimicrobial susceptibility.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
- 650 _2
- $a síran vápenatý $7 D002133
- 650 _2
- $a vankomycin $x farmakologie $7 D014640
- 650 _2
- $a kostní cementy $x farmakologie $x terapeutické užití $7 D001843
- 650 12
- $a ortopedie $7 D009985
- 650 _2
- $a agar $7 D000362
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a polymethylmethakrylát $x chemie $7 D019904
- 650 12
- $a ortopedické výkony $7 D019637
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fulín, Petr $u 1. Orthopedic Clinic First Faculty of Medicine Charles University and University Hospital in Motol, Prague $7 xx0231618
- 700 1_
- $a Nyč, Otakar $u Department of Medical Microbiology Second Faculty of Medicine Charles University and University Hospital in Motol, Prague $7 uk2007399535
- 700 1_
- $a Gajdošová, Veronika, $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague $d 1991- $7 xx0283084
- 700 1_
- $a Pokorný, David, $u 1. Orthopedic Clinic First Faculty of Medicine Charles University and University Hospital in Motol, Prague $d 1968- $7 jn20001103568
- 700 1_
- $a Šlouf, Miroslav, $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague $d 1973- $7 xx0107048
- 773 0_
- $w MED00011021 $t Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $x 0001-5415 $g Roč. 90, č. 3 (2023), s. 188-197
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37395426 $y Pubmed
- 910 __
- $a ABA008 $b A 8 $c 507 $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230802075150 $b ABA008
- 999 __
- $a ok $b bmc $g 1964383 $s 1195228
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 90 $c 3 $d 188-197 $e - $i 0001-5415 $m Acta chirurgiae orthopaedicae et traumatologiae Čechoslovaca $n Acta chir. orthop. traumatol. Čechoslovaca $x MED00011021
- LZP __
- $b NLK198 $a Pubmed-20230707